Hertrust 440mg Injection contains Trastuzumab and is prescribed for HER2-positive breast cancer. This type of cancer is characterized by breast cancer cells with a high concentration of HER2 proteins, which accelerate tumor growth by signaling the cancer. It is also used for metastatic gastric cancer with elevated HER2 protein levels.
HER2-positive breast cancers are known for their aggressive nature. Hertrust is a targeted therapy that specifically attacks the proteins driving cancer's growth, development, and spread. You must use effective birth control during treatment and for at least 7 months after your last dose.
Hertrust 440mg Injection is not suitable for individuals under 18, or those experiencing severe breathing difficulties or requiring oxygen. Inform your doctor if you have heart conditions, shortness of breath, or have undergone prior cancer treatments. Before starting Hertrust, disclose all medications, supplements, and herbal remedies you are taking.
Option 2: Patient-Focused and Informative
Hertrust 440mg Injection, with Trastuzumab as its active ingredient, is a treatment for HER2-positive breast cancer. In HER2-positive patients, the cancer cells have many HER2 proteins, which act as signals that cause tumors to grow quickly. This injection is also used to treat metastatic gastric cancer if HER2 protein levels are high.
HER2-positive breast cancers are typically more aggressive. Hertrust is a targeted therapy that works by precisely targeting the proteins responsible for the cancer's growth, development, and spread. It's crucial to use effective birth control throughout your treatment and for at least 7 months after your final dose.
Hertrust 440mg Injection is not recommended for patients younger than 18, or for those with severe breathing problems or who need oxygen therapy. You must inform your physician if you have any heart issues, experience breathlessness, or have a history of other cancer treatments. Before starting this medication, make sure your physician knows about all the medicines you are taking, including any supplements or herbal medicines.
Option 3: Slightly More Formal and Clinical
Hertrust 440mg Injection, comprising Trastuzumab, is indicated for the treatment of HER2-positive breast cancer. In HER2-positive patients, breast cancer cells exhibit a high abundance of HER2 proteins, which serve as signals for rapid tumor development. This medication is also employed in the management of metastatic gastric cancer with elevated HER2 protein levels.
HER2-positive breast cancers are characterized by their aggressive nature. This targeted therapy functions by selectively inhibiting the proteins that mediate cancer growth, development, and dissemination. Effective contraception is mandatory during the treatment period and for a minimum of 7 months following the final administration.
Hertrust 440mg Injection is contraindicated in patients under 18 years of age, and in individuals with severe respiratory compromise or requiring supplemental oxygen. It is essential to disclose any history of cardiac conditions, dyspnea, or prior oncological treatments to your physician. Patients must inform their physician of all concomitant medications, including supplements and herbal remedies, prior to initiating therapy.
Option 4: Concise Summary for Quick Reference
Hertrust 440mg Injection (Trastuzumab) treats HER2-positive breast cancer and metastatic gastric cancer with high HER2 levels. It targets proteins driving aggressive cancer growth. Use effective birth control during and for 7 months after treatment. Not for patients under 18, with severe breathing problems, or on oxygen. Inform your doctor about heart issues, breathlessness, prior cancer treatments, and all current medications (including supplements/herbal).

The Hertrust 440mg Injection is used in the treatment of the following:

Advanced and metastatic breast cancer
Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hertrust 440mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hertrust 440mg Injection and cause undesirable side effects.

v